IDXX - IDEXX LABORATORIES INC /DE
608.41
-10.510 -1.727%
Share volume: 539,203
Last Updated: 03-06-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$618.92
-10.51
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-01-2024 | 08-06-2024 | 10-31-2024 | 02-21-2025 | 05-01-2025 | 08-04-2025 | 11-03-2025 | 02-20-2026 | |
| Assets | |||||||||
| Total Assets | 3.354 B | 3.415 B | 3.351 B | 3.293 B | 3.214 B | 3.331 B | 3.387 B | 3.351 B | |
| Current Assets | 1.502 B | 1.529 B | 1.434 B | 1.400 B | 1.318 B | 1.362 B | 1.477 B | 1.414 B | |
| Inventories | 390.599 M | 379.958 M | 389.804 M | 381.877 M | 395.987 M | 392.584 M | 391.564 M | 377.756 M | |
| Other Current Assets | 206.733 M | 213.458 M | 224.054 M | 256.179 M | 230.192 M | 244.616 M | 310.444 M | 303.623 M | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 397.433 M | 401.590 M | 308.636 M | 288.266 M | 163.970 M | 164.594 M | 208.166 M | 180.070 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 708.725 M | 708.178 M | 717.745 M | 713.123 M | 717.624 M | 739.677 M | 739.437 M | 747.380 M | |
| Other Assets | 1.143 B | 1.178 B | 1.199 B | 1.180 B | 1.178 B | 1.229 B | 1.170 B | 1.190 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 3.354 B | 3.415 B | 3.351 B | 3.293 B | 3.214 B | 3.331 B | 3.387 B | 3.351 B | |
| Total liabilities | 1.785 B | 1.835 B | 1.733 B | 1.698 B | 1.766 B | 1.872 B | 1.826 B | 1.745 B | |
| Total current liabilities | 956.902 M | 1.117 B | 1.009 B | 1.068 B | 1.136 B | 1.224 B | 1.252 B | 1.149 B | |
| Accounts Payable | 117.462 M | 117.468 M | 110.603 M | 114.211 M | 120.096 M | 116.585 M | 122.265 M | 110.408 M | |
| Other liabilities | 170.140 M | 156.361 M | 166.299 M | 142.177 M | 144.735 M | 164.425 M | 164.115 M | 157.678 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 620.778 M | 524.743 M | 524.758 M | 449.786 M | 449.799 M | 449.812 M | 374.825 M | 374.842 M | |
| Other liabilities | 170.140 M | 156.361 M | 166.299 M | 142.177 M | 144.735 M | 164.425 M | 164.115 M | 157.678 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 1.569 B | 1.580 B | 1.618 B | 1.595 B | 1.448 B | 1.459 B | 1.561 B | 1.605 B | |
| Common stock | 1.621 B | 1.642 B | 1.663 B | 1.691 B | 1.712 B | 1.744 B | 1.810 B | 1.844 B | |
| Retained earnings | 4.680 B | 4.883 B | 5.116 B | 5.332 B | 5.575 B | 5.869 B | 6.144 B | 6.392 B |